# The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA

> **NCT05138289** · — · COMPLETED · sponsor: **HeartFlow, Inc.** · enrollment: 258 (actual)

## Conditions studied

- Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))

## Interventions

- **OTHER:** Total Plaque Volume

## Key facts

- **NCT ID:** NCT05138289
- **Lead sponsor:** HeartFlow, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-12
- **Primary completion:** 2022-11-08
- **Final completion:** 2022-11-08
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05138289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05138289, "The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05138289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*